Mostrar el registro sencillo del ítem

Clinical Response to a Lapatinib-Based Therapy for a Li-Fraumeni Syndrome Patient with a Novel HER2(V659E) Mutation

dc.contributor.authorSerra, Violeta
dc.contributor.authorVivancos, Ana
dc.contributor.authorSuárez Puente, Xosé Antón 
dc.contributor.authorFelip, Enriqueta
dc.contributor.authorSilberschmidt, Daniel
dc.contributor.authorCaratù, Ginevra
dc.contributor.authorParra, Josep-Lluís
dc.contributor.authorMattos Arruda, Leticia de
dc.contributor.authorGrueso, Judit
dc.contributor.authorHernández-Losa, Javier
dc.contributor.authorArribas, Joaquín
dc.contributor.authorPrudkin, Ludmila
dc.contributor.authorNuciforo, Paolo
dc.contributor.authorScaltriti, Maurizio
dc.contributor.authorSeoane Leston, Juan
dc.contributor.authorBaselga, José
dc.date.accessioned2014-04-04T08:14:16Z
dc.date.available2014-04-04T08:14:16Z
dc.date.issued2013
dc.identifier.citationCancer Discovery, 3(11), p. 1238-1244 (2013); doi:10.1158/2159-8290.CD-13-0132
dc.identifier.issn2159-8274
dc.identifier.issn2159-8290
dc.identifier.urihttp://hdl.handle.net/10651/25220
dc.description.sponsorshipThis work has been supported by the European Research Council grants (ERC AdG09 250244 to J. Baselga and ERC 205819 to J. Seoane), Instituto de Salud Carlos III (ISCIII) grants (PSO9/00623 to J. Baselga, PI070648 to J. Seoane, and PI1202536 to J. Arribas), and Redes Temáticas de Investigación Cooperativa en Salud (RETIC)-ISCIII (RD06/06/0020/0075 to J. Baselga, RD12/0036/0043 to J. Seoane, and RD12/0036/0042 to J. Arribas), Asociación Española contra el Cáncer AECC grants (to J. Seoane and J. Arribas), a Rafael del Pino Foundation grant (to J. Baselga), a private donation from the Orozco family through the Oncology Research Foundation, FERO (to J.Baselga), and the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (to J. Baselga).
dc.format.extentp. 1238-1244
dc.language.isoeng
dc.relation.ispartofCancer Discovery
dc.rights© 2013 American Association for Cancer Research
dc.sourceWOS:000328256400021
dc.titleClinical Response to a Lapatinib-Based Therapy for a Li-Fraumeni Syndrome Patient with a Novel HER2(V659E) Mutation
dc.typejournal article
dc.identifier.local20141081
dc.identifier.doi10.1158/2159-8290.CD-13-0132
dc.relation.publisherversionhttp://dx.doi.org/10.1158/2159-8290.CD-13-0132


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem